Highline Wealth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.1K Buy
82
+5
+6% +$1.38K ﹤0.01% 418
2026
Q1
$22.7K Buy
77
+1
+1% +$297 0.01% 276
2025
Q4
$20.8K Sell
76
-19
-20% -$5.16K 0.01% 253
2025
Q3
$25.7K Buy
95
+1
+1% +$272 0.01% 231
2025
Q2
$25.9K Buy
94
+43
+84% +$11.7K 0.01% 191
2025
Q1
$13.5K Sell
51
-11
-18% -$2.71K ﹤0.01% 259
2024
Q4
$14.4K Buy
62
+19
+44% +$4.37K ﹤0.01% 204
2024
Q3
$9.49K Buy
43
+30
+231% +$6.21K ﹤0.01% 261
2024
Q2
$2.56K Buy
+13
New +$2.69K ﹤0.01% 363
2022
Q4
Sell
-6
Closed -$1.06K 334
2022
Q3
$1.06K Buy
+6
New +$1.19K ﹤0.01% 258

Other funds holding CME

Highline Wealth Partners's CME Position: Q2 2026 in Review

Highline Wealth Partners increased its CME Group (CME) stake by 6.5% in Q2 2026, buying an estimated $1.38K and bringing the position to 82 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #418.

Highline Wealth Partners first reported a position in CME in Q3 2022 and has held it in 10 quarters since. The position peaked at $25.9K in Q2 2025. 333 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Highline Wealth Partners held 82 shares of CME Group worth $18.1K as of Q2 2026.
  • Highline Wealth Partners bought 5 CME Group shares in Q2 2026, an estimated $1.38K.
  • CME Group made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #418 holding.
  • Highline Wealth Partners first reported a position in CME Group in Q3 2022 and has held it in 10 quarters since.
  • Highline Wealth Partners's CME Group position peaked at $25.9K in Q2 2025.
  • 333 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.